CDC Recommends Doxy PEP As First New STI Prevention Tool In Decades

By Luke Zarzecki / June 5, 2024 at 6:39 PM

The Centers for Disease Control and Prevention (CDC) on Tuesday (June 4) recommended clinicians counsel at-risk patients on use of doxycycline postexposure prophylaxis (doxy PEP) to prevent bacterial sexually transmitted disease infections, marking the first new STI prevention tool from federal health officials in decades.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.